Treatments not currently available in Australia outside clinical trials
Research continues to develop new and/or improved treatments to treat lung and other types of cancers. Many investigational treatments are medicines which work in different ways to target and kill cancer cells. Some of these investigational treatments appear to have fewer side effects as they do less harm to healthy cells.
Investigational treatment types include:
- Monoclonal antibodies: these are man-made (engineered) antibodies that target specific cancer proteins.
- Anti-angiogenesis drugs: angiogenesis is the process by which new blood vessels are made. Anti-angiogenesis drugs target the blood vessels that supply blood to the tumours. Without these blood vessels, the tumour has less blood supply and cannot grow.
- Lung cancer vaccines: these treatments aim to stimulate an immune response against the tumour, so the body will fight it.
- Targeted therapies: treatments which block certain aspects of cancer cell functions (see EGFRs for more information).
While all these treatments are using highly specialised science, the goal for all of them is to find more effective ways to stop cancer cells spreading, and killing existing tumours. Specialist doctors, such as medical oncologists, will have more information on these and other new treatments currently being developed.
Note: Medical oncologists will have more information on new treatments for lung cancer currently being developed. These doctors will also have information on clinical research trials of some new treatments, which may be another treatment option in lung cancer.